Buy Genferon Light suppositories vaginal-rectal 250000ed N10

Genferon Light suppositories vaginal-rectal 250000ed N10

Condition: New product

997 Items

$26.56

More info

Active ingredients

Interferon Alfa-2b + Taurine

Release form

Suppositories

Composition

Active ingredient: Interferon alpha-2b, Taurine (Taurine) Active ingredient concentration (mg): 5

Pharmacological effect

Pharmacological action - antiviral, immunomodulatory, antioxidant.

Pharmacokinetics

Rectal or vaginal suppositories During rectal administration of the drug, there is a high bioavailability (more than 80%) of interferon, and therefore both local and pronounced systemic immunomodulatory effects are achieved; with intravaginal use, due to the high concentration in the focus of infection and fixation on the cells of the mucous membrane of the vagina, a pronounced local antiviral, antiproliferative and antibacterial effect is achieved, while the systemic action due to the low absorption capacity of the mucous membrane of the vagina is negligible. Cmax of serum interferon is reached 5 h after drug administration. The main route of elimination is through the kidneys. T1 / 2 is 12 hours, which necessitates the use of the drug 2 times a day. Spray nasal In intranasal use due to the high concentration in the focus of infection, a pronounced local antiviral and immunostimulating effect is achieved. Systemic absorption of the drug slightly - low bioavailability of drugs with intranasal administration associated with a special family of proteins from 25 proteins that make up the mucous membrane of the nasal cavity and control the transport of all molecular and cellular volumes comrade penetrating slizistuyu.V the same time, a certain amount of the drug reaches the systemic circulation, thereby achieving systemic immunomodulatory effect.

Indications

- for the treatment of infectious and inflammatory diseases of the urogenital tract in children and women, including pregnant women; - as a component of complex therapy - for the treatment of other infectious diseases of viral etiology.

Contraindications

Individual intolerance to interferon and other substances that make up the drug. With care: exacerbation of allergic and autoimmune diseases.

Use during pregnancy and lactation

Vaginal or rectal suppositories Clinical studies have proven the efficacy and safety of using Genferon Light in women aged 13–40 weeks of gestation. Use in the first trimester of pregnancy is contraindicated. It has no restrictions for use during lactation. Spray nasal dosageApplication is allowed during the entire period of pregnancy.

Dosage and administration

The drug can be used both vaginally and rectally. The method of administration, the dosage and the duration of the course depend on the age, the specific clinical situation and are determined by the attending physician. Generon Light is used in adults and children over 7 years of age at a dosage of 250,000 IU interferon alfa-2b per suppository. In children under 7 years old, it is safe to use the drug at a dosage of 125,000 IU of interferon alpha-2b per suppository. Recommended doses and treatment regimens: Acute infectious and inflammatory diseases of the urogenital tract in children: 1 suppository rectally 2 times a day with a 12-hour interval for 10 days. Infectious-inflammatory diseases of the urogenital tract in pregnant women: 1 suppository vaginally 2 times a day with a 12-hour interval for 10 days. Infectious-inflammatory diseases of the urogenital tract in women: 1 suppository (250 000 ME) vaginally or rectally (depending on the nature of the disease) 2 times a day with a 12-hour interval for 10 days. With prolonged forms 3 times a week every other day, 1 suppository for 1-3 months. Acute infectious and inflammatory diseases of viral etiology in children: 1 suppository rectally 2 times a day with a 12-hour interval in parallel with the standard therapy for 5 days. If symptoms persist, the course of treatment is repeated after a 5-day interval. Chronic infectious and inflammatory diseases of viral etiology in children: 1 suppository rectally 2 times a day with a 12-hour interval in parallel with the standard therapy for 10 days. Then within 1-3 months - 1 suppository rectally for a night every other day.

Side effects

The drug is well tolerated. Local allergic reactions are possible (sensation of itching and burning in the vagina). These phenomena are reversible and disappear within 72 hours after cessation of administration.Continuation of treatment is possible after consulting a doctor. Until now, no serious or life-threatening side effects have been observed. Phenomena occurring when all types of interferon alfa-2b are used, such as chills, fever, fatigue, loss of appetite, muscle and headaches, pain in joints, sweating, and leuko- and thrombocytopenia, but more often they occur when exceeding daily dose in excess of 10 million ME. In these cases, it is recommended to consult the attending physician to decide whether to discontinue the drug or reduce the dose. As with any other interferon alfa, if the temperature rises after its administration, a single dose of paracetamol can be taken in a dose of 500-1000 mg for adults and 250 mg for children.

Overdose

Vaginal or rectal suppositories: The cases of overdose of Genferon Light are not registered. In case of a random one-time administration of a larger number of suppositories than prescribed by a doctor, further administration should be suspended for 24 hours, after which treatment can be resumed according to the prescribed regimen. Spray nasal dosage No cases of overdose of Genferon Light were reported.

Interaction with other drugs

Vaginal or rectal suppositories Genferon Light is most effective as a component of complex therapy. When combined with antibacterial, fungicidal and antiviral drugs, mutual potentiation of action is observed, which allows to achieve a high total therapeutic effect. Spray nasal dosageNot marked.

special instructions

Vaginal or rectal suppositories. Effects on the ability to drive vehicles and mechanisms. Genferon Light does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving vehicles, machinery, etc.).

Reviews